Metastatic Brain Tumors

Also known as: Metastases, Brain / Metastatic Brain Tumor / Metastases to Brain / Brain cancer metastatic / Brain Metastases / Secondary malignant neoplasm of brain / Brain secondaries / Metastasis to brain

DrugDrug NameDrug Description
DB00262CarmustineA cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
DB01206LomustineAn alkylating agent of value against both hematologic malignancies and solid tumors. [PubChem]
DB00635PrednisoneA synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver. [PubChem]
DB00620TriamcinoloneA glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (From Martindale, The Extra Pharmacopoeia, 30th ed, p739)
DrugDrug NamePhaseStatusCount
DB09063Ceritinib0Recruiting1
DB00072Trastuzumab0Withdrawn1
DB06769Bendamustine1Terminated1
DB00290Bleomycin1Terminated1
DB00530Erlotinib1Completed1
DB00773Etoposide1Completed1
DB01259Lapatinib1Completed2
DB12060RRx-0011Active Not Recruiting1
DB04996Satraplatin1Completed1
DB00398Sorafenib1Completed1
DB00398Sorafenib1Recruiting1
DB01268Sunitinib1Active Not Recruiting1
DB00853Temozolomide1Completed2
DB00853Temozolomide1Terminated1
DB00072Trastuzumab1Completed1
DB00313Valproic Acid1Completed1
DB00313Valproic Acid1Terminated1
DB02546Vorinostat1Completed1
DB00112Bevacizumab1 / 2Withdrawn1
DB00958Carboplatin1 / 2Completed1
DB01016Glyburide1 / 2Recruiting1
DB11737Icotinib1 / 2Completed1
DB06186Ipilimumab1 / 2Not Yet Recruiting1
DB00853Temozolomide1 / 2Completed1
DB00853Temozolomide1 / 2Withdrawn1
DB00072Trastuzumab1 / 2Completed1
DB12001Abemaciclib2Recruiting1
DB00112Bevacizumab2Completed1
DB00112Bevacizumab2Recruiting3
DB11666Buparlisib2Active Not Recruiting1
DB01101Capecitabine2Active Not Recruiting1
DB00515Cisplatin2Completed2
DB00515Cisplatin2Recruiting3
DB08912Dabrafenib2Not Yet Recruiting1
DB11727Endostar2Unknown Status1
DB08871Eribulin2Recruiting1
DB00530Erlotinib2Completed1
DB00530Erlotinib2Unknown Status2
DB00773Etoposide2Completed1
DB00773Etoposide2Recruiting1
DB00317Gefitinib2Recruiting1
DB11737Icotinib2Recruiting1
DB11737Icotinib2Unknown Status1
DB06186Ipilimumab2Active Not Recruiting3
DB00762Irinotecan2Completed1
DB01259Lapatinib2Completed1
DB04967Lucanthone2Suspended1
DB00563Methotrexate2Completed1
DB09035Nivolumab2Active Not Recruiting1
DB09037Pembrolizumab2Recruiting2
DB00642Pemetrexed2Completed1
DB00642Pemetrexed2Not Yet Recruiting1
DB00642Pemetrexed2Recruiting2
DB12257Platinum2Completed1
DB05920RTA 7442Terminated1
DB00641Simvastatin2Completed1
DB00853Temozolomide2Completed2
DB00853Temozolomide2Terminated1
DB00853Temozolomide2Unknown Status1
DB05007Tesevatinib2Recruiting1
DB11973Tesevatinib2Recruiting1
DB01030Topotecan2Unknown Status1
DB08911Trametinib2Not Yet Recruiting1
DB00072Trastuzumab2Active Not Recruiting1
DB00072Trastuzumab2Completed1
DB00317Gefitinib2 / 3Recruiting1
DB01101Capecitabine3Active Not Recruiting1
DB04106Fotemustine3Recruiting1
DB06703Gadobutrol3Completed1
DB00597Gadoteridol3Completed1
DB06186Ipilimumab3Recruiting1
DB01259Lapatinib3Active Not Recruiting1
DB09035Nivolumab3Recruiting1
DB00072Trastuzumab3Active Not Recruiting1